Option Care Health (OPCH) Stock Price, News & Analysis

Company Overview

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Key Stats

• Today's Range: $28.13 to $29.54
• 50-Day Range: $28.26 to $32.83
• 52-Week Range: $21.39 to $35.53
• Volume: 1.84 million shs
• Average Volume: 1.42 million shs
• Market Capitalization: $4.59 billion
• P/E Ratio: 22.61
• Dividend Yield: N/A
• Price Target: $35.75
• Consensus Rating: Moderate Buy

Option Care Health Stock Analysis - MarketRank™

Option Care Health scored higher than 93% of companies evaluated by MarketBeat, and ranked 71st out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Option Care Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Option Care Health has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 3.28%

Earnings Growth

Earnings for Option Care Health are expected to grow by 3.28% in the coming year, from $1.22 to $1.26 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Option Care Health is 22.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Option Care Health is 22.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.67.

Price to Earnings Growth Ratio

Option Care Health has a PEG Ratio of 1.86. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Option Care Health has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.90% of the float of Option Care Health has been sold short.

Short Interest Ratio / Days to Cover

Option Care Health has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Option Care Health has recently increased by 6.82%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Option Care Health does not currently pay a dividend.

Dividend Growth

Option Care Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.3 / 5
• Environmental Score: -3.06

Percentage of Shares Shorted

2.90% of the float of Option Care Health has been sold short.

Short Interest Ratio / Days to Cover

Option Care Health has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Option Care Health has recently increased by 6.82%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 1.46

News Sentiment

Option Care Health has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Option Care Health this week, compared to 8 articles on an average week.

Search Interest

3 people have searched for OPCH on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

MarketBeat Follows

1 people have added Option Care Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Option Care Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.64% of the stock of Option Care Health is held by insiders.

Percentage Held by Institutions

98.05% of the stock of Option Care Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OPCH Stock Analysis - Frequently Asked Questions

How have OPCH shares performed this year?

Option Care Health's stock was trading at $23.20 at the beginning of 2025. Since then, OPCH stock has increased by 21.8% and is now trading at $28.26.

How were Option Care Health's earnings last quarter?

Option Care Health, Inc. (NASDAQ:OPCH) announced its quarterly earnings data on Wednesday, July, 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm's revenue for the quarter was up 15.4% compared to the same quarter last year.
Read the conference call transcript.

Who are Option Care Health's major shareholders?

Option Care Health's top institutional shareholders include Jennison Associates LLC (1.31%), Allspring Global Investments Holdings LLC (0.95%), Riverbridge Partners LLC (0.77%) and Fort Washington Investment Advisors Inc. OH (0.54%). Insiders that own company stock include Walgreens Boots Alliance, Inc, Harry M Jansen Kraemer Jr, Michael H Shapiro, R Carter Pate, Michael Bavaro, Elizabeth Quadros Betten, Elizabeth D Bierbower and Collin Smyser.
View institutional ownership trends.

How do I buy shares of Option Care Health?

Shares of OPCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Option Care Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Option Care Health investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), AU Optronics (AUOTY), The RMR Group (RMR) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 7/30/2025
• Today: 8/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:OPCH
• CIK: 1014739
• Web: www.optioncarehealth.com
• Phone: (312) 940-2443
• Fax: 952-979-3969
• Employees: 8,088
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Option Care Health: $35.75
• High Price Target: $41.00
• Low Price Target: $27.00
• Potential Upside/Downside: +26.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.25
• Trailing P/E Ratio: 22.61
• Forward P/E Ratio: 23.16
• P/E Growth: 1.86
• Net Income: $211.82 million
• Net Margins: 3.93%
• Pretax Margin: 5.34%
• Return on Equity: 17.53%
• Return on Assets: 7.17%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 1.52
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: $5.00 billion
• Price / Sales: 0.92
• Cash Flow: $1.58 per share
• Price / Cash Flow: 17.84
• Book Value: $8.38 per share
• Price / Book: 3.37

Miscellaneous

• Outstanding Shares: 162,290,000
• Free Float: 162,699,000
• Market Cap: $4.59 billion
• Optionable: Optionable
• Beta: 0.79